It may also help investigate how persistent SARS‐CoV‐2‐induced inflammation affects secondary infections such as respiratory syncytial virus (RSV), where we recently reported exacerbated disease upon pre‐existing increased expression of IL‐1α and TNF‐α [49]. This evidence concerns the gene TNF and infection.